Cite
HARVARD Citation
Nirogi, R. et al. (n.d.). Masupirdine (SUVN‐502) in combination with donepezil and memantine in moderate Alzheimer's disease: Effect of AD duration since diagnosis and patient's age on efficacy endpoints. Alzheimer's & dementia. p. n/a. [Online].